PTEN, another tumor suppressor associated with HIF-1 activity, exhibits germline mutations that increase the risk of developing cancer, particularly glioblastomas, highly vascularized tumors associated with high VEGF levels [107]. This evidence concerns the gene HIF1A and cancer.